Literature DB >> 23320858

Preliminary findings suggest hidradenitis suppurativa may be due to defective follicular support.

F W Danby1, G B E Jemec, W Ch Marsch, M von Laffert.   

Abstract

BACKGROUND: The initial pathology in hidradenitis suppurativa (HS)/acne inversa takes place in the folliculopilosebaceous unit (FPSU) and its surrounding tissue. The process involves follicular hyperkeratosis, inflammation and perifolliculitis. Identification of the exact origin of inflammation may shed new light on the pathogenesis and aetiology of the disease.
OBJECTIVES: To study the morphology of the basement membrane zone (BMZ) in patients with HS.
METHODS: In total, 65 operative specimens from 20 patients diagnosed with HS were cut stepwise. Within each specimen, the focus was set on heavily involved HS regions (centre) and clinically uninvolved regions (border). All specimens were stained with periodic acid-Schiff (PAS) to visualize the epithelial support structures of the FPSU (i.e. the BMZ), the sinus tracts (STs) and the interfollicular basement membrane (BM). The intensity of BMZ PAS staining was graded from 0 to 4+.
RESULTS: Compared with the axillary skin of human controls, the sebofollicular junction in patients with HS was found to be almost devoid of PAS-positive material (grade 0/1+) in both the border and centre lesions of HS, whereas STs and BMs showed uniformly grade 2-3+ positivity irrespective of any inflammation present. The distribution of inflammatory cells around the sebofollicular junction occurred predominantly in areas of BMZ thinning.
CONCLUSIONS: The BMZ PAS positivity of clinically uninvolved FPSUs of patients with HS appears to be wispy or not present at all. It is speculated that this may explain the apparent fragility of the sebofollicular junction. There is an increased concentration of inflammatory cells adjacent to these areas, while inflammatory cells are scarce in areas where the PAS-positive material is intact. It is hypothesized that the PAS gap identifies (i) areas susceptible to leakage, trauma and rupture, leading to release of materials that trigger inflammatory mediators, and (ii) the seeding of the dermis with free-living stem cells generating benign but invasive epithelialized sinuses, spreading horizontally in and below the dermis.
© 2013 The Authors. BJD © 2013 British Association of Dermatologists.

Entities:  

Mesh:

Year:  2013        PMID: 23320858     DOI: 10.1111/bjd.12233

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  15 in total

Review 1.  [Hidradenitis suppurativa/acne inversa: An update].

Authors:  J Kirschke; S Hessam; F G Bechara
Journal:  Hautarzt       Date:  2015-06       Impact factor: 0.751

2.  Interferon-gamma (IFN-γ) is Elevated in Wound Exudate from Hidradenitis Suppurativa.

Authors:  Anirban Banerjee; Sean McNish; Victoria K Shanmugam
Journal:  Immunol Invest       Date:  2016-11-07       Impact factor: 3.657

3.  Nicastrin haploinsufficiency alters expression of type I interferon-stimulated genes: the relationship to familial hidradenitis suppurativa.

Authors:  L Cao; D J Morales-Heil; E D O Roberson
Journal:  Clin Exp Dermatol       Date:  2019-01-17       Impact factor: 3.470

Review 4.  Advances in molecular pathogenesis of hidradenitis suppurativa: Dysregulated keratins and ECM signaling.

Authors:  Mahendra Pratap Kashyap; Jasim Khan; Rajesh Sinha; Lin Jin; Venkatram Atigadda; Jessy S Deshane; Ayesha R Ahmed; Ali Kilic; Chander Raman; M Shahid Mukhtar; Craig A Elmets; Mohammad Athar
Journal:  Semin Cell Dev Biol       Date:  2022-02-04       Impact factor: 7.499

Review 5.  Hidradenitis suppurativa.

Authors:  Robert Sabat; Gregor B E Jemec; Łukasz Matusiak; Alexa B Kimball; Errol Prens; Kerstin Wolk
Journal:  Nat Rev Dis Primers       Date:  2020-03-12       Impact factor: 52.329

Review 6.  North American clinical management guidelines for hidradenitis suppurativa: A publication from the United States and Canadian Hidradenitis Suppurativa Foundations: Part II: Topical, intralesional, and systemic medical management.

Authors:  Ali Alikhan; Christopher Sayed; Afsaneh Alavi; Raed Alhusayen; Alain Brassard; Craig Burkhart; Karen Crowell; Daniel B Eisen; Alice B Gottlieb; Iltefat Hamzavi; Paul G Hazen; Tara Jaleel; Alexa B Kimball; Joslyn Kirby; Michelle A Lowes; Robert Micheletti; Angela Miller; Haley B Naik; Dennis Orgill; Yves Poulin
Journal:  J Am Acad Dermatol       Date:  2019-03-11       Impact factor: 15.487

Review 7.  Update on hidradenitis suppurativa: connecting the tracts.

Authors:  Liza Gill; Melissa Williams; Iltefat Hamzavi
Journal:  F1000Prime Rep       Date:  2014-12-01

8.  Dissecting cellulitis (DSC) after interferon beta-1a treatment and scalp trauma.

Authors:  Jeff Donovan
Journal:  JAAD Case Rep       Date:  2015-08-25

Review 9.  [Clinical, pathology-associated and molecular biomarkers of hidradenitis suppurativa/acne inversa].

Authors:  M von Laffert; R E Hunger; A A Navarini; C C Zouboulis
Journal:  Hautarzt       Date:  2021-07-02       Impact factor: 0.751

10.  Histologic progression of acne inversa/hidradenitis suppurativa: Implications for future investigations and therapeutic intervention.

Authors:  Robert W Dunstan; Katherine M Salte; Viktor Todorović; Margaret Lowe; Joseph B Wetter; Paul W Harms; Richard E Burney; Victoria E Scott; Kathleen M Smith; Michael D Rosenblum; Johann E Gudjonsson; Prisca Honore
Journal:  Exp Dermatol       Date:  2021-01-20       Impact factor: 3.960

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.